‘False, deceptive and misleading:’ Johnson & Johnson to pay $572 million in landmark opioid trial, judge rules

The judge’s landmark decision is the first in the nation to hold a drug company responsible for contributing to the opioid crisis. There are hundreds of similar lawsuits pending across the U.S. in state and federal courts